michal amit rahat
Department of Immunology, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology
Haifa, Israel
Associate Editor
Cancer Immunity and Immunotherapy
Department of Immunology, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology
Haifa, Israel
Associate Editor
Cancer Immunity and Immunotherapy
Pfizer (United States)
New York, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Tübingen
Tübingen, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Earle A. Chiles Research Institute
Portland, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of British Columbia
Vancouver, Canada
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Scientific Institute of Romagna for the Study and Treatment of Tumors (IRCCS)
Meldola, Italy
Associate Editor
Cancer Immunity and Immunotherapy
German Cancer Research Center (DKFZ)
Heidelberg, Germany
Associate Editor
Cancer Immunity and Immunotherapy
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Associate Editor
Cancer Immunity and Immunotherapy
The University of Queensland
Brisbane, Australia
Associate Editor
Cancer Immunity and Immunotherapy
Institut Curie
Paris, France
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Arcellx Inc
Gaithersburg, United States
Associate Editor
Cancer Immunity and Immunotherapy
School of Medicine, Yale University
New Haven, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Perugia
Perugia, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University Hospital Frankfurt
Frankfurt, Germany
Associate Editor
Cancer Immunity and Immunotherapy